|
Volumn 167, Issue 5, 2001, Pages 2452-2455
|
Cutting edge: Amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(β-o-methyl)-fluoromethylketone
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOBENZOXYVALYLALANYLASPARTYL(BETA O METHYL)FLUOROMETHYLKETONE;
CASPASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
AUTOIMMUNE DISEASE;
CONTROLLED STUDY;
FEMALE;
IMMUNE COMPLEX DISEASE;
KIDNEY DISEASE;
LUPUS ERYTHEMATOSUS NEPHRITIS;
MORTALITY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SKIN INFLAMMATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TRANSGENIC MOUSE;
|
EID: 0035451099
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: 10.4049/jimmunol.167.5.2452 Document Type: Article |
Times cited : (42)
|
References (21)
|